Re: Karlsson et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study (multiple letters) [1]

Rheumatology

Volumn 42, Issue 10, 2003, Pages 1262-1263

  Magilavy, D ^b,c   Polisson, R ^b   Parenti, D ^a   Karlsson, J ^d   Sjogren L ^d   Lohmander, S ^d  

^a PFIZER INC   (United States)

^b GENZYME CORPORATION   (United States)

^c Department of Clinical Research   (United States)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTZAL; BUFFER; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; PHOSPHATE; PLACEBO; SODIUM CHLORIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LETTER; MULTICENTER STUDY; OSTEOPHYTE; OUTCOMES RESEARCH; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE; TREATMENT OUTCOME;

EID: 0141962658     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg310     Document Type: Letter

References (0)